CORT vs. TXMD
CORT (Corcept Therapeutics Incorporated) and TXMD (TherapeuticsMD, Inc.) are both stocks. Both are in the Healthcare sector — CORT in Biotechnology, TXMD in Drug Manufacturers - Specialty & Generic. Over the past 10 years, CORT returned 31.34%/yr vs -41.36%/yr for TXMD. At a 0.14 correlation, their price movements are largely independent.
Performance
CORT vs. TXMD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CORT achieves a 129.05% return, which is significantly higher than TXMD's 22.70% return. Over the past 10 years, CORT has outperformed TXMD with an annualized return of 31.34%, while TXMD has yielded a comparatively lower -41.36% annualized return.
CORT
- 1D
- -0.25%
- 1M
- 32.36%
- YTD
- 129.05%
- 6M
- -6.34%
- 1Y
- 11.67%
- 3Y*
- 53.92%
- 5Y*
- 29.06%
- 10Y*
- 31.34%
TXMD
- 1D
- 2.56%
- 1M
- -5.66%
- YTD
- 22.70%
- 6M
- 19.05%
- 1Y
- 83.49%
- 3Y*
- -21.02%
- 5Y*
- -49.35%
- 10Y*
- -41.36%
CORT vs. TXMD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CORT Corcept Therapeutics Incorporated | 129.05% | -30.94% | 55.14% | 59.92% | 2.58% | -24.31% | 116.20% | -9.43% | -26.02% | 148.76% |
TXMD TherapeuticsMD, Inc. | 22.70% | 89.53% | -61.78% | -59.75% | -68.55% | -70.62% | -50.00% | -36.48% | -36.92% | 4.68% |
Correlation
The correlation between CORT and TXMD is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.11 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Apr 14, 2004 | 0.14 |
Fundamentals
CORT:
$8.32B
TXMD:
$23.28M
CORT:
$0.41
TXMD:
$0.02
CORT:
194.37
TXMD:
129.49
CORT:
96.82
TXMD:
0.15
CORT:
12.03
TXMD:
8.82
CORT:
13.05
TXMD:
0.86
CORT:
$769.10M
TXMD:
$2.63M
CORT:
$755.64M
TXMD:
$2.63M
CORT:
$3.66M
TXMD:
-$3.12M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CORT vs. TXMD — Risk / Return Rank
CORT
TXMD
CORT vs. TXMD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and TherapeuticsMD, Inc. (TXMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CORT | TXMD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.95 | ||
| Sortino ratioReturn per unit of downside risk | -1.20 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.27 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | 0.18 | 2.45 | -2.27 |
| Martin ratioReturn relative to average drawdown | 0.33 | 5.07 | -4.74 |
Loading charts...
Drawdowns
CORT vs. TXMD - Drawdown Comparison
The maximum CORT drawdown since its inception was -94.29%, smaller than the maximum TXMD drawdown of -99.89%. Use the drawdown chart below to compare losses from any high point for CORT and TXMD.
Loading charts...
Drawdown Indicators
| CORT | TXMD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.29% | -99.89% | +5.60% |
Max Drawdown (1Y)Largest decline over 1 year | -64.40% | -34.30% | -30.10% |
Max Drawdown (3Y)Largest decline over 3 years | -71.85% | -82.98% | +11.13% |
Max Drawdown (5Y)Largest decline over 5 years | -71.85% | -98.88% | +27.03% |
Max Drawdown (10Y)Largest decline over 10 years | -71.85% | -99.83% | +27.98% |
Current DrawdownCurrent decline from peak | -30.21% | -99.64% | +69.43% |
Average DrawdownAverage peak-to-trough decline | -53.43% | -61.26% | +7.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.39% | 16.51% | +18.88% |
Volatility
CORT vs. TXMD - Volatility Comparison
The current volatility for Corcept Therapeutics Incorporated (CORT) is 13.61%, while TherapeuticsMD, Inc. (TXMD) has a volatility of 26.78%. This indicates that CORT experiences smaller price fluctuations and is considered to be less risky than TXMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CORT | TXMD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.61% | 26.78% | -13.17% |
Volatility (6M)Calculated over the trailing 6-month period | 85.06% | 47.73% | +37.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 77.18% | 76.29% | +0.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 74.59% | 189.69% | -115.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 67.22% | 146.04% | -78.82% |
Dividends
CORT vs. TXMD - Dividend Comparison
Neither CORT nor TXMD has paid dividends to shareholders.
Financials
CORT vs. TXMD - Financials Comparison
This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and TherapeuticsMD, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CORT and TXMD have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TXMD has higher volatility (26.78%) compared to CORT (13.61%). In terms of maximum drawdown, CORT dropped -94.29% vs TXMD's -99.89%.
TXMD currently has the higher Sharpe Ratio (1.10 vs 0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CORT and TXMD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer